Similar articles

• A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).

  Mani D, Neil N, Israel R, Aboulafia DM. Mani D, et al. J Int Assoc Physicians AIDS Care (Chic). 2009 Sep-Oct;8(5):279-85. doi: 10.1177/1545109709341852. Epub 2009 Aug 31. J Int Assoc Physicians AIDS Care (Chic). 2009. PMID: 19721098
• [Update on Kaposi's sarcoma].

  Morand JJ, Lightburn E, Simon F, Patte JH. Morand JJ, et al. Med Trop (Mars). 2007 Apr;67(2):123-30. Med Trop (Mars). 2007. PMID: 17691428 Review. French.
• Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma.

  Somos S, Farkas B. Somos S, et al. Anticancer Res. 2000 Jan-Feb;20(1B):541-5. Anticancer Res. 2000. PMID: 10769722
• Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.

  Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C. Bihl F, et al. AIDS. 2007 Jun 19;21(10):1245-52. doi: 10.1097/QAD.0b013e328182df03. AIDS. 2007. PMID: 17545700 Clinical Trial.
• [Kaposi's disease].

  Lebbé C. Lebbé C. Rev Prat. 1999 Apr 15;49(8):843-7. Rev Prat. 1999. PMID: 10337197 Review. French.